Empagliflozin Treatment in Kidney Transplant Recipients
Conditions: Kidney Transplant; Type 2 Diabetes Intervention: Drug: Empagliflozin Sponsors: VA Office of Research and Development; Iowa City VA Health Care System; VA Pittsburgh Healthcare System; Nashville VA Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Empagliflozin | Endocrinology | Jardiance | Kidney Transplant | Kidney Transplantation | Research | Transplant Surgery | Transplants | Urology & Nephrology